» Articles » PMID: 8662804

Phosphorylation of Ser211 in the Chicken Progesterone Receptor Modulates Its Transcriptional Activity

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1996 May 31
PMID 8662804
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The chicken progesterone receptor has been shown to be phosphorylated in vivo at four major sites. Previous studies have shown that mutation of one of the hormone-dependent phosphorylation sites, Ser530, to alanine decreases the transcriptional activity of the receptor under conditions where ligand is limited. Here, we present evidence for the functional significance of another phosphorylation site, Ser211. Mutation of Ser211 to alanine results in a decrease in the transcriptional activity of the receptor and affects the phosphorylation-dependent decrease in mobility of the receptor in SDS-polyacrylamide gel electrophoresis. The degree of reduction in transcriptional activity is dependent on both the cell type and the reporters used in the studies but is independent of hormone concentration, suggesting that phosphorylation at Ser211 regulates the activity of the receptor through a mechanism distinct from Ser530 phosphorylation.

Citing Articles

Modulation of transcriptional mineralocorticoid receptor activity by casein kinase 2.

Ruhs S, Stratz N, Quarch K, Masch A, Schutkowski M, Gekle M Sci Rep. 2017; 7(1):15340.

PMID: 29127314 PMC: 5681688. DOI: 10.1038/s41598-017-15418-1.


Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG.

Roberts J, San Martin R, Piyarathna D, MacKrell J, Rocha G, Dodge J Oncotarget. 2017; 8(27):44447-44464.

PMID: 28591703 PMC: 5546493. DOI: 10.18632/oncotarget.17968.


Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells.

Krause W, Shafi A, Nakka M, Weigel N Int J Biochem Cell Biol. 2014; 54:49-59.

PMID: 25008967 PMC: 4160387. DOI: 10.1016/j.biocel.2014.06.013.


Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells.

Nakka M, Agoulnik I, Weigel N Int J Biochem Cell Biol. 2012; 45(4):763-72.

PMID: 23270728 PMC: 3593820. DOI: 10.1016/j.biocel.2012.12.012.


Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation.

Yang Y, Tse A, Li P, Ma Q, Xiang S, Nicosia S Oncogene. 2011; 30(19):2207-18.

PMID: 21242980 PMC: 3093431. DOI: 10.1038/onc.2010.600.